Acne Vulgaris

At the initial visit, record inflammatory lesions (papules, pustules, nodules), noninflammatory lesions (open and closed comedones), involved sites, prior treatment response, and psychosocial impact. A practical global framework defines mild disease as predominantly comedonal with few inflammatory lesions, moderate disease as many comedonal and inflammatory lesions, and severe disease as substantial inflammatory disease with papules and pustules predominant and possible nodulocystic lesions. fda+2fda[PDF] Statistical Review and Evaluation Clinical Studies (ACZONE) - FDAaccessdata fda[PDF] Adapalene Topical Lotion - accessdata.fda.govfda[PDF] clinical review - FDA

Treat palpable nodules as an escalation signal rather than simply a higher lesion count. In FDA acne-study definitions, a nodule is a deep palpable solid lesion greater than 0.5 cm; nodular or cystic disease is at heightened risk for scarring and warrants prompt consideration of isotretinoin rather than repeated topical or antibiotic cycles. fda+2fda[PDF] clinical review - FDAScienceDirectGuidelines of care for the management of acne vulgaris - ScienceDirectaadAmerican Academy of Dermatology issues updated guidelines for ...

Ask specifically about treatment-related irritation, product use, adherence, menstrual association, medication exposures, fever, myalgia, arthralgia, and psychological effect. History should also capture virilization features, including hirsutism, androgen-pattern hair loss, deepening voice, or genital enlargement, because these findings redirect the visit toward evaluation of androgen excess. PubMedPubMedAcne Vulgaris - StatPearls - NCBI Bookshelf

Topical retinoids and benzoyl peroxide receive strong guideline recommendations and are appropriate foundational therapies for acne management. Topical antibiotics also have a strong recommendation, but should be deployed only within a combination regimen rather than as standalone therapy. ScienceDirect+1ScienceDirectGuidelines of care for the management of acne vulgaris - ScienceDirectaadAmerican Academy of Dermatology issues updated guidelines for ...

For comedonal-predominant disease, select a topical retinoid as the central agent and reassess clinical response at approximately 12 weeks. FDA study programs for adapalene, tretinoin, and tazarotene evaluate treatment response at day 84, and retinoid-associated sun-exposure precautions include sunscreen and protective clothing when sun avoidance is not feasible. accessdata fda+2accessdata fda[PDF] Tretinoin Topical Lotion - accessdata.fda.govaccessdata fda[PDF] Tazarotene Topical Aerosol Foam - accessdata.fda.govaccessdata fda[PDF] Adapalene Topical Lotion - accessdata.fda.gov

For mixed inflammatory and comedonal acne, combine a topical retinoid with benzoyl peroxide and consider adding a topical antibiotic when the inflammatory component warrants it. This approach addresses multiple acne pathways while avoiding topical-antibiotic monotherapy, which promotes bacterial resistance. ScienceDirect+2ScienceDirectGuidelines of care for the management of acne vulgaris - ScienceDirectScienceDirectAnalyzing trends in treatment of acne vulgaris and adherence to the American Academy of Dermatology guidelines: A retrospective studyaadAmerican Academy of Dermatology issues updated guidelines for ...

Conditional topical alternatives include clascoterone, azelaic acid, and salicylic acid. These are reasonable additions or substitutions when tolerability, patient preference, contraindications, or phenotype makes a standard retinoid-benzoyl peroxide regimen unsuitable, but the guideline strength is lower than for benzoyl peroxide and topical retinoids. ScienceDirectScienceDirectGuidelines of care for the management of acne vulgaris - ScienceDirect

Oral doxycycline is strongly recommended for acne requiring systemic antibiotic therapy. Oral minocycline and sarecycline are conditionally recommended alternatives. Combine systemic antibiotics with topical therapies, including benzoyl peroxide, and limit their duration to reduce resistance and antibiotic-associated complications. ScienceDirect+1ScienceDirectGuidelines of care for the management of acne vulgaris - ScienceDirectaadAmerican Academy of Dermatology issues updated guidelines for ...

Do not use systemic antibiotic monotherapy. A benzoyl peroxide-containing topical regimen should remain in place during oral antibiotic treatment to reduce resistance selection; when the oral antibiotic is stopped, continue nonantibiotic topical therapy for disease control. ScienceDirect+1ScienceDirectAnalyzing trends in treatment of acne vulgaris and adherence to the American Academy of Dermatology guidelines: A retrospective studyaadAmerican Academy of Dermatology issues updated guidelines for ...

Oral isotretinoin is strongly recommended for severe acne, acne producing scarring or psychosocial burden, and acne that has failed standard oral or topical therapy. These indications justify referral or treatment planning before serial antibiotic courses create further delay in a patient with active scarring disease. ScienceDirect+1ScienceDirectGuidelines of care for the management of acne vulgaris - ScienceDirectaadAmerican Academy of Dermatology issues updated guidelines for ...

For an individual large inflammatory lesion causing pain or at risk of persistent inflammation, intralesional corticosteroid injection is a guideline-endorsed adjunct for more rapid relief. It treats the focal lesion but does not replace systemic treatment for generalized nodular acne. ScienceDirect+1ScienceDirectGuidelines of care for the management of acne vulgaris - ScienceDirectaadAmerican Academy of Dermatology issues updated guidelines for ...

At follow-up, compare lesion counts, global severity, new nodules, truncal involvement, scarring progression, adverse effects, and patient-reported psychosocial burden against baseline. FDA acne trials commonly use lesion counts and investigator global assessments at 12 weeks, but global ratings can vary between investigators; serial use of the same method is more informative than switching scales. accessdata fda+3accessdata fda[PDF] Tretinoin Topical Lotion - accessdata.fda.govfda[PDF] Statistical Review and Evaluation Clinical Studies (ACZONE) - FDAaccessdata fda[PDF] Tazarotene Topical Aerosol Foam - accessdata.fda.govfda[PDF] clinical review - FDA

Interpret persistent disease in context. New nodules, scar formation, or worsening psychosocial burden should trigger escalation even if the total lesion count falls. In contrast, irritation, inconsistent use, or unrecognized overlapping topical products should be corrected before labeling a retinoid- or benzoyl peroxide-based regimen ineffective.

After stopping an oral antibiotic, maintain disease control with nonantibiotic topical therapy. Maintenance evidence has been evaluated in randomized trials, and guideline practice emphasizes combination topical therapies and limited systemic antibiotic exposure rather than chronic antibiotic treatment. ScienceDirect+2ScienceDirectGuidelines of care for the management of acne vulgaris - ScienceDirectaadAmerican Academy of Dermatology issues updated guidelines for ...PubMedMaintenance treatments for acne vulgaris - NCBI Bookshelf